Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Cowen & Co. Downgrades PhaseBio Pharmaceuticals to Market Perform

Cowen & Co. Downgrades PhaseBio Pharmaceuticals to Market Perform

Cowen & Co. analyst Phil Nadeau downgrades PhaseBio Pharmaceuticals (NASDAQ:PHAS) from Outperform to Market Perform.

October 24, 2022

1 minute read

Cowen & Co. analyst Phil Nadeau downgrades PhaseBio Pharmaceuticals (NASDAQ:PHAS) from Outperform to Market Perform.

Short Squeeze Goes To Moon And Back In A Day. Why Getty Images Dropped Double Digits Today

September 16, 12:36 PM

Getty Images Holdings, Inc (NYSE:GETY) filed a prospectus with the SEC for a possible sale of 401 million Class A common…

May 1, 11:21 AM

Alibaba to build data center in Vietnam to comply with local storage law and meet demand. Other tech firms also diversifying to Vietnam.

August 26, 11:39 AM

-Reuters

July 14, 8:49 AM

Canopy Growth (NASDAQ:CGC) (TSX:WEED) shares were trading 19.07% lower at $0.5260 during Friday’s pre-market session. What happened: Cannabis…